South Korea
· Delayed Price · Currency is KRW DNA Link Statistics
Total Valuation
DNA Link has a market cap or net worth of KRW 111.07 billion. The enterprise value is 116.12 billion.
| Market Cap | 111.07B |
| Enterprise Value | 116.12B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DNA Link has 22.48 million shares outstanding. The number of shares has increased by 8.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 22.48M |
| Shares Change (YoY) | +8.99% |
| Shares Change (QoQ) | +5.86% |
| Owned by Insiders (%) | 4.48% |
| Owned by Institutions (%) | n/a |
| Float | 17.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.87 |
| PB Ratio | 4.21 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.26 |
| EV / Sales | 6.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.22 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.14 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.41 |
| Interest Coverage | -16.53 |
Financial Efficiency
Return on equity (ROE) is -44.91% and return on invested capital (ROIC) is -12.86%.
| Return on Equity (ROE) | -44.91% |
| Return on Assets (ROA) | -9.97% |
| Return on Capital (ROIC) | -12.86% |
| Revenue Per Employee | 235.08M |
| Profits Per Employee | -139.68M |
| Employee Count | 81 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +59.10% |
| 50-Day Moving Average | 3,871.70 |
| 200-Day Moving Average | 3,182.23 |
| Relative Strength Index (RSI) | 73.97 |
| Average Volume (20 Days) | 271,002 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DNA Link had revenue of KRW 19.04 billion and -11.31 billion in losses. Loss per share was -602.59.
| Revenue | 19.04B |
| Gross Profit | 3.92B |
| Operating Income | -7.06B |
| Pretax Income | -11.31B |
| Net Income | -11.31B |
| EBITDA | -5.58B |
| EBIT | -7.06B |
| Loss Per Share | -602.59 |
Balance Sheet
The company has 9.59 billion in cash and 14.63 billion in debt, giving a net cash position of -5.05 billion or -224.40 per share.
| Cash & Cash Equivalents | 9.59B |
| Total Debt | 14.63B |
| Net Cash | -5.05B |
| Net Cash Per Share | -224.40 |
| Equity (Book Value) | 26.39B |
| Book Value Per Share | 1,173.76 |
| Working Capital | 2.92B |
Cash Flow
In the last 12 months, operating cash flow was -8.78 billion and capital expenditures -1.57 billion, giving a free cash flow of -10.35 billion.
| Operating Cash Flow | -8.78B |
| Capital Expenditures | -1.57B |
| Free Cash Flow | -10.35B |
| FCF Per Share | -460.27 |
Margins
Gross margin is 20.56%, with operating and profit margins of -37.09% and -59.42%.
| Gross Margin | 20.56% |
| Operating Margin | -37.09% |
| Pretax Margin | -59.42% |
| Profit Margin | -59.42% |
| EBITDA Margin | -29.32% |
| EBIT Margin | -37.09% |
| FCF Margin | n/a |
Dividends & Yields
DNA Link does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.99% |
| Shareholder Yield | -8.99% |
| Earnings Yield | -12.20% |
| FCF Yield | -9.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DNA Link has an Altman Z-Score of -0.9. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.9 |
| Piotroski F-Score | n/a |